HUAK Stock Overview
Huake Holding Biology Co., Ltd. produces and sells camellia seed oil products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Huake Holding Biology Co., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.00 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HUAK | US Food | US Market | |
|---|---|---|---|
| 7D | n/a | -1.1% | -3.7% |
| 1Y | n/a | -14.0% | 20.5% |
Return vs Industry: Insufficient data to determine how HUAK performed against the US Food industry.
Return vs Market: Insufficient data to determine how HUAK performed against the US Market.
Price Volatility
| HUAK volatility | |
|---|---|
| HUAK Average Weekly Movement | n/a |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HUAK has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HUAK's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 27 | Pingting Wang | www.aokaifa.ns2.mfdns.com |
Huake Holding Biology Co., Ltd. produces and sells camellia seed oil products. It sells its products through direct sales, sales exhibitions, franchising, and online distribution channels. The company also exports its products to Taiwan, Hong Kong, and Southeast Asia.
Huake Holding Biology Co., LTD. Fundamentals Summary
| HUAK fundamental statistics | |
|---|---|
| Market cap | US$31.25m |
| Earnings (TTM) | US$2.90m |
| Revenue (TTM) | US$21.11m |
10.8x
P/E Ratio1.5x
P/S RatioIs HUAK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUAK income statement (TTM) | |
|---|---|
| Revenue | US$21.11m |
| Cost of Revenue | US$17.03m |
| Gross Profit | US$4.08m |
| Other Expenses | US$1.18m |
| Earnings | US$2.90m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 19.35% |
| Net Profit Margin | 13.74% |
| Debt/Equity Ratio | 0% |
How did HUAK perform over the long term?
See historical performance and comparison